Ross Cohen
Podiatrist · Pasadena, MDNPI 1548268485
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,444 of the $8,369 with a category attached, or 65.1%. Arthrex accounts for 79.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $4,812 and has fallen 98.2% since, to $88 in 2025. Among podiatrist clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $194.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$7K
- Supreme Orthopedic Systems, LLC$454
- Amgen$255
- Smith+Nephew$223
- Musculoskeletal Transplant Foundation Inc.$155
- Nevro Corp.$128
- plus $472 from 5 others
What the payments were for
- Travel & lodging$1,31916%
- Food & beverage$1,60619%
- Education$5,44465%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $6,682 |
| Supreme Orthopedic Systems, LLC | 5 | $454 |
| Amgen | 3 | $255 |
| Smith+Nephew | 3 | $223 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $155 |
| Nevro Corp. | 1 | $128 |
| Convatec Inc. | 1 | $125 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Triad Life Sciences Inc. | 1 | $112 |
| Native Surgical, LLC | 1 | $88 |
| Cashflow Solutions, LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$238
- InnovaMatrix AC$237
- Senza$128
- Baxdela$125
- REGRANEX$112
- COLLAGENASE SANTYL$106
How this compares
$8,369 in reported general payments places this provider in the 90th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 22 | $404 |
| Mupirocin | 22 | $181 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Pasadena
- Ira GottliebPasadena$25K
- Enzo LeonePasadena$15K
- Jenny NguyenPasadena$15K
- Steven GershPasadena$2K
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Teresa HilliardHyattsville$19K
- Andreas KaikisHagerstown$17K
- Tiffany HohBaltimore$17K
- Shashank SrivastavaFrederick$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.